Pulse

German manufacturer Gerresheimer AG has entered into definitive agreements to sell its Centor prescription packaging business and its global Primary Packaging Plastics division to funds advised by Apax Partners for a combined enterprise value of approximately €1.5bn. Gerresheimer, a global partner for the pharmaceutical, biotech, and cosmetics industries, confirmed that the transaction includes 15 production sites for primary plastic packaging…

Dutch-Belgian immunology group argenx SE has entered a definitive agreement to acquire US-based biopharma group Forte Biosciences in an all-cash transaction valued at approximately $2.2bn. This deal, the largest in the history of the Euronext-listed firm, marks a significant pivot as argenx seeks to diversify its portfolio beyond its flagship blockbuster treatment, Vyvgart. Under the terms of the agreement, argenx…

Global private investment firm Bain Capital is to acquire British vitamin and mineral supplement company Vitabiotics. Announced on Friday, July 24, the deal marks a significant consolidation in the European consumer healthcare sector. The transaction values the UK’s leading nutraceutical firm at approximately £900m (roughly $1.2bn). This acquisition includes the core British operations and the wider VB Group, which encompasses…

Leading pan-European provider of community-based clinics and advanced diagnostics Affidea has announced a strategic partnership with London International Patient Services (LIPS Healthcare). LIPS Healthcare is the largest private consultant-led multi-specialty group in the UK. For operators and investors, the deal signals a move towards scalable, out-of-hospital care models that respond to the evolving demand for accessible outpatient services. As part…

French hospital operator Ramsay Santé, which is preparing for a landmark separation from its Australian parent company, has just finalised a €1.75bn senior debt refinancing It closed the transaction on Wednesday, July 22, securing a new financial framework that facilitates its transition toward becoming a standalone European healthcare leader. The transaction provides significant breathing room as the business pursues its independent…

Healthcare Activos launched its newest strategic vehicle, Healthcare Activos Hospitals, on Tuesday, July 22. Created in partnership with a group of long term institutional investors, the platform has an initial investment target of €800m.  The platform has acquired three hospitals in Portugal from Praemia REIM and Icade for a total transaction value, including planned expansion capital, of up to €250…

Samsung Biologics, a leading South Korean CDMO that provides integrated services from discovery to commercial production, has entered into a definitive agreement to acquire Swiss listed PolyPeptide Group in a deal valuing the company at CHF 1.46bn (€1.57bn). PolyPeptide is a Swiss based specialist contract manufacturer of peptide based active pharmaceutical ingredients used by major pharmaceutical and biotechnology firms globally.…

Global private investment firm Ardian is acquiring a majority stake in Berlin-based digital healthcare recruitment platform Pflegia. Founded in 2019, Pflegia operates an AI powered reverse recruiting platform that connects healthcare professionals with care providers by matching candidate preferences with institutional needs. This transaction marks a significant move for Ardian Growth, the specialist team within the firm that focuses on…

European middle market private equity firm Inflexion is acquiring Primed Group from DACH focused private equity firm Paragon Partners. The transaction, which is being executed through Inflexion’s Buyout Fund VI, marks the firm’s sixth investment in the DACH region. The financial terms of the deal remain undisclosed, and the transaction is subject to customary regulatory approvals. The acquisition highlights the…

Spire Healthcare has been the focus of two major transactions, with Toscafund’s potential £1.01bn takeover bid extended to August 6, while Blue Owl Capital has completed a £1.3bn acquisition of 12 Spire hospital properties. Toscafund Asset Management is the company’s second largest shareholder. It submitted a non-binding proposal in May 2026 to acquire the remaining 82 per cent of the…